# Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112

> **NCT00088517** · PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 10 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [11C]NNC-112

## Key facts

- **NCT ID:** NCT00088517
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 10 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00088517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00088517, "Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00088517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*